Antitumor effects of radionuclide treatment using α-emitting meta-(211)At-astato-benzylguanidine in a PC12 pheochromocytoma model

PURPOSE: Therapeutic options for patients with malignant pheochromocytoma are currently limited, and therefore new treatment approaches are being sought. Targeted radionuclide therapy provides tumor-specific systemic treatments. The β-emitting radiopharmaceutical meta-(131)I-iodo-benzylguanidine ((1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Ohshima, Yasuhiro, Sudo, Hitomi, Watanabe, Shigeki, Nagatsu, Kotaro, Tsuji, Atsushi B., Sakashita, Tetsuya, Ito, Yoichi M., Yoshinaga, Keiichiro, Higashi, Tatsuya, Ishioka, Noriko S.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915519/
https://ncbi.nlm.nih.gov/pubmed/29350258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3919-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados